Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

Black-gray, hard leathery tissue is called eschar (see Figure 7). Hypergranulation tissue has a sort, flaccid texture very different from normal granulation tissue. Odor in wounds is a significant ...

Typical lesions progress from red or gray macules or papules, to red or gray macules or papules with a central eschar or ulceration ... Panafil® was applied to the wound to loosen the necrotic ...

MediWound (MDWD) shares ended the last trading session 8.5% higher at $19.83. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...

MediWound’s first drug, NexoBrid ®, is an FDA- and EMA-approved orphan biologic for eschar removal in deep ... for the debridement of chronic wounds. Phase II clinical trials have shown ...